catalyst · primary record
HORIZANT
Patent expiry · 2026-11-10 · GABAPENTIN ENACARBIL
| Company | AZURITY PHARMACEUTICALS INC |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 8026279 expires · GABAPENTIN ENACARBIL |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-11-02T01:48:07.260Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: AZURITY PHARMACEUTICALS INC:HORIZANT:2026-11-10:US 8026279 expires · GABAPENTIN ENACARBIL
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.